Ottobock
German orthopedic-technology company specializing in prosthetics, orthotics, wheelchairs, rehabilitation products and exoskeletons.
Last updated August 31, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Ottobock SE & Co. KGaA is a German medical-technology company headquartered in Duderstadt. Its principal activities are the development, manufacture and supply of prosthetic limbs, orthotic systems, mobility equipment, rehabilitation products and wearable exoskeletons. The company is widely regarded as a global leader in prosthetics and has a substantial international presence in orthotics, wheelchairs and assistive technologies. The business originated in the aftermath of the First World War, when large numbers of injured veterans required artificial limbs and orthopedic care. Otto Bock helped establish Orthopädische Industrie GmbH in Berlin in 1919. The company moved production to Königsee in Thuringia in 1920 and began replacing purely artisanal production with standardized, industrially manufactured prosthetic components. Otto Bock became the company's managing director in 1924 and sole managing director in 1927. The company's history also includes serious ethical controversies. During the National Socialist period, Otto Bock joined the NSDAP and became a supporting member of the SS. The company used forced labor during the Second World War, including Russian women employed in production-related departments. After the war, the family's assets and the Königsee plant were confiscated in the Soviet occupation zone. The company subsequently relocated to Duderstadt in West Germany in 1946. Postwar growth was driven by product innovation and internationalization. Plastics entered production in the 1950s, while the Jüpa knee helped establish a major commercial position in prosthetic components. Ottobock exported the product to the United States and opened an American branch in Minneapolis in 1958. Later milestones included the introduction of myoelectric arm prostheses in 1965, the modular pyramid adapter in 1969 and the C-Leg, one of the first commercially prominent microprocessor-controlled knee joints, in 1997. Since the 1990s, the company has expanded beyond traditional prosthetic components. It has developed electronically controlled knees and feet, sensor-equipped orthoses, manual and powered wheelchairs, pediatric rehabilitation products, cranial orthoses and industrial exoskeletons. Acquisitions such as BeBionic, BionX Medical Technologies, Pohlig and SuitX broadened its technological and clinical capabilities. The group also operates patient-care and medical-supply businesses in some markets. Ottobock remains controlled by the Näder family through Näder Holding. Swedish investment firm EQT acquired a minority interest in 2017, but the family repurchased the relevant shares in 2024. The company has periodically considered an initial public offering, including a plan discussed for 2022 that was abandoned amid unfavorable market conditions. Its Russian operations have generated criticism following Russia's invasion of Ukraine, while earlier regulatory and legal matters included a U.S. antitrust case involving Freedom Innovations, a Russian procurement investigation and allegations concerning public-health funding in Bosnia. In 2024, the wider group reported sales of approximately EUR 1.6 billion and about 9,100 employees in 45 countries, according to the supplied reference material.
History
Ottobock was established in Berlin on 13 January 1919 as Orthopädische Industrie GmbH. The founding initiative was associated with Otto Bock, a manufacturer from Krefeld, and addressed the urgent need for prosthetic and orthopedic products after the First World War. Manufacturing moved to Königsee in Thuringia in 1920, where the company developed standardized production methods for prosthetic components. Otto Bock assumed management in 1924 and became sole managing director in 1927. The company's conduct and ownership history during the National Socialist era remain important parts of its history. Otto Bock joined the NSDAP in 1933 and was a supporting member of the SS. The original company was liquidated and reorganized under the Otto Bock name. During the Second World War, the business used forced labor, including Russian women working in production departments. Max Näder, who later became central to the company's ownership and leadership, trained at the business and married Otto Bock's daughter Maria in 1943. After the war, Soviet authorities confiscated the family's private assets and the Königsee factory. The company established itself in Duderstadt in 1946, which remains its headquarters. Plastics were introduced into production in 1950. The Jüpa knee, developed after the war, provided a major commercial breakthrough, and exports to the United States began with 500 units in 1955. Ottobock established a U.S. branch in Minneapolis in 1958, beginning the international sales structure that later developed into a global network. Product development accelerated under Max Näder. Myoelectric arm prostheses entered the market in 1965, enabling users to control a prosthesis through weak electrical muscle signals. The pyramid adapter, patented in 1969, made modular alignment and later component replacement easier in lower-limb prostheses. The company continued to combine mechanical engineering with electronics, materials science and clinical fitting. After German reunification, Hans Georg Näder took over management from his father in 1990. Ottobock reacquired the former Königsee site in the same year; the location later became associated with wheelchairs, pediatric rehabilitation products and seating systems. In 1997, the company introduced the C-Leg, a microprocessor-controlled knee joint that became one of its best-known products. The company marked its 90th anniversary with the opening of the Science Center Medical Technology in Berlin in 2009, and it adopted a new international logo in 2011. During the 2010s, Ottobock broadened its portfolio through internal development and acquisitions. It acquired BeBionic in 2017, BionX Medical Technologies in the same year and expanded its orthotic activities through Pohlig, which became wholly owned in 2018. The company also developed sensor-equipped orthoses and established a Bionic Exoskeletons business. In 2019, reported group sales passed EUR 1 billion for the first time. The company was nevertheless required to divest Freedom Innovations after U.S. competition authorities challenged the effects of its acquisition of the prosthesis manufacturer. The group continued investing in wearable robotics and mobility technology, acquiring SuitX in 2021. Its ownership and financing structure became a major corporate issue. EQT had acquired a 20 percent interest in 2017, while the company explored an IPO. A proposed 2022 listing was postponed and ultimately not pursued amid difficult market conditions. Leadership changes in 2022 produced a new executive team. In 2023, Ottobock acquired the Brillinger medical-supply-store chain, while it also faced a patent lawsuit concerning 3D-printed cranial-helmet components. In March 2024, Näder Holding completed the repurchase of the minority stake previously held by EQT. The group reported 2024 sales of approximately EUR 1.6 billion and about 9,100 employees in 45 countries in the supplied reference material.
- 2024
Näder Holding completes stake repurchase
[1]The family holding company completed the repurchase of EQT's minority interest.
- 2021
SuitX acquired
[1]Ottobock acquired exoskeleton developer SuitX to strengthen its wearable-robotics business.
- 2017
EQT acquires minority stake
[1]EQT acquired a 20 percent interest in Ottobock.
- 1997
C-Leg presented
[1]Ottobock presented its microprocessor-controlled knee joint at the World Prosthetics Congress.
- 1990
Hans Georg Näder assumes management
[1]Leadership passed to the founder's grandson, while Ottobock reacquired its former Königsee site.
- 1969
Pyramid adapter patented
[1]The modular adapter enabled improved alignment and interchangeability of lower-limb prosthetic components.
- 1965
Myoelectric arm prostheses launched
[1]The company commercialized arm prostheses controlled by electrical signals from residual muscles.
- 1958
First U.S. branch opens
[1]Ottobock opened an American branch in Minneapolis, supporting international expansion.
- 1946
Headquarters established in Duderstadt
[1]After postwar confiscation of the Königsee plant, the company settled in Duderstadt.
- 1920
Production moves to Königsee
[1]Manufacturing relocated to Thuringia, where industrial production of prosthetic components was developed.
Products and positioning
Premium, technology-led orthopedic care and assistive mobility, combining component engineering with clinical fitting, rehabilitation and patient-specific solutions.
Microprocessor-controlled prosthetic knee · 1997
C-Leg
The C-Leg is a computer-controlled lower-limb prosthetic knee introduced in 1997. Sensors and control software adjust resistance during different phases of walking, supporting greater stability and more adaptive movement than conventional mechanical knees. It established Ottobock as a prominent developer of electronically controlled prosthetic joints.
Myoelectric hand prosthesis
BeBionic
BeBionic is a myoelectric hand system acquired by Ottobock from Steeper in 2017. It uses muscle signals to control hand movements and offers multiple grip patterns intended for everyday activities. The product extended Ottobock's upper-limb portfolio beyond traditional hooks and mechanically operated hands.
Microprocessor-controlled prosthetic knee
Genium
Genium is a digitally controlled prosthetic knee family designed to coordinate stance and swing behavior across varied walking conditions. It represents Ottobock's higher-end approach to powered or electronically assisted lower-limb mobility and is typically fitted through specialist clinical and rehabilitation channels.
Orthopedic braces and supports
Orthoses
Ottobock produces orthotic systems for the legs, spine and upper limbs. Its portfolio includes mechanically articulated and sensor-equipped devices intended to support joints, influence gait and assist people with neurological or musculoskeletal conditions. Some newer systems use electronics to manage stance and swing phases during walking.
Mobility and rehabilitation equipment
Wheelchairs and rehabilitation systems
The company supplies manual and powered wheelchairs, seating products, pediatric rehabilitation equipment and related mobility solutions. Production at the Königsee site has been associated with wheelchairs and rehabilitation products, complementing Ottobock's prosthetics and orthotics businesses.
Wearable robotics · 2018
Bionic Exoskeletons
Ottobock's exoskeleton business develops wearable systems intended to support industrial workers or people with mobility limitations. The portfolio expanded significantly through the acquisition of SuitX, whose technology originated from university robotics research and addressed ergonomic load reduction and assisted movement.
Controversies
2023
Patent-infringement lawsuit over cranial helmets
Cranial Technologies filed a patent-infringement action against Ottobock and Active Life concerning an alleged unauthorized 3D-printing process for infant cranial-helmet components.
2020
Russian antimonopoly fine
A Russian Ottobock subsidiary was fined over suspected cartel behavior in state prosthetics tenders. Authorities alleged that the conduct gave Ottobock and other parties an improper position in procurement valued at 168.1 million Russian rubles.
2019
U.S. competition-law dispute over Freedom Innovations
The U.S. Federal Trade Commission challenged Ottobock's acquisition of Freedom Innovations on competition grounds. Ottobock sold the business and related assets in 2019; the divestiture was reported as causing a substantial financial impact.
2016
Bosnian public-health funding controversy
An investigation reported that Ottobock was implicated in a controversy involving the misuse of public health funds in Bosnia and alleged pressure on prosthetic users to obtain its products. The company was subsequently banned from operating in parts of the country.
1933
National Socialist affiliations and forced labor
Otto Bock joined the NSDAP and was a supporting member of the SS. During the Second World War, the company used forced labor, including Russian women in production-related work. These facts form a documented and controversial part of the company's historical record.
Criticism over continued Russian operations
Ottobock has faced criticism for continuing operations in Russia, including manufacturing activity in Tolyatti, after Russia's invasion of Ukraine.
Brand decisions
2024
Näder Holding repurchases EQT stakeM&ABackground
The Näder family sought to restore direct control after EQT had held a minority position since 2017.
Action taken
Näder Holding repurchased EQT's 20 percent interest.
Aftermath
The Näder family regained full ownership control according to the supplied reference material.
Repurchase price. EUR 1.1 billion (March 2024)
2022
Postpone proposed initial public offeringStrategyBackground
Ottobock had explored a public listing but faced difficult capital-market conditions and valuation uncertainty.
Action taken
The company postponed and then abandoned the planned 2022 IPO.
Aftermath
The company remained privately held and underwent substantial executive-management changes.
2021
Acquire SuitXM&ABackground
Ottobock identified wearable robotics and exoskeletons as an expansion area beyond conventional orthopedic products.
Action taken
It acquired U.S. exoskeleton company SuitX.
Aftermath
SuitX technology was integrated into Ottobock's exoskeleton activities.
2019
Divest Freedom InnovationsM&ABackground
The FTC challenged the competitive effects of Ottobock's acquisition of Freedom Innovations.
Action taken
Ottobock sold Freedom Innovations and assets connected with the acquisition to Proteor.
Aftermath
The divestiture addressed the competition-law dispute and reduced Ottobock's position in the relevant U.S. prosthetics market.
Reported financial impact. EUR 78.1 million impact reported (2019)
2017
Acquire BeBionic and BionXM&ABackground
Ottobock sought to strengthen its upper-limb prosthetics and robotic mobility technologies.
Action taken
It acquired BeBionic from Steeper and Boston-based BionX Medical Technologies.
Aftermath
The transactions broadened the company's myoelectric-hand and robotic-foot offerings.
Recent events
- 2024
Näder Holding repurchases EQT's minority stake[1]
M&A
Näder Holding completed the repurchase of the minority interest previously held by EQT, restoring full family control according to the supplied reference material.
- 2022
Ottobock restructures senior management[1]
Leadership change
A new four-member executive leadership team took operational responsibility after changes involving several previous managing directors.
- 2021
Ottobock acquires SuitX[1]
M&A · Product generation
The company acquired U.S. exoskeleton developer SuitX to expand its wearable robotics business.
- 2017
Ottobock acquires BeBionic[1]
M&A · Product launch
Ottobock acquired the BeBionic myoelectric hand and arm prosthesis business from Steeper.
- 1997
Ottobock presents the C-Leg[1]
Product launch · Product generation
Ottobock presented its C-Leg microprocessor-controlled knee joint at the World Prosthetics Congress in Nuremberg.
- 1965
Ottobock introduces myoelectric arm prostheses[1]
Product launch
The company brought myoelectric arm prostheses to market, using electrical signals from residual muscles to control movement.
Sources3 sources
Cite this profile: Cite the canonical profile. /brand-wiki/ottobock · Editorial policy · How profiles are compiled